We are live on ! Find out more
GCL

Glazer Capital LLC Portfolio holdings

AUM $4.71B
1-Year Est. Return 81.93%
This Fund
S&P 500
This Quarter Est. Return
+4.3%
1 Year Est. Return
+81.93%
3 Year Est. Return
+319.13%
5 Year Est. Return
+526.52%
10 Year Est. Return
+4,797.43%
AUM
$3.86B
AUM Growth
-$1.59B
Cap. Flow
-$1.68B
Cap. Flow %
-43.43%
Top 10 Hldgs %
19.14%
Holding
821
New
112
Increased
267
Reduced
93
Closed
295
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LEGA
26
DELISTED
Lead Edge Growth Opportunities, Ltd Class A Ordinary Shares
LEGA
$31.7M 0.82%
3,147,773
+664,272
+27% +$6.65M
ANAC
27
DELISTED
Arctos NorthStar Acquisition Corp.
ANAC
$31.6M 0.82%
3,130,152
-17,348
-0.6% -$174K
VEEA
28
Veea Inc
VEEA
$8.93M
$31.3M 0.81%
3,105,760
-21,011
-0.7% -$210K
CSTA
29
DELISTED
Constellation Acquisition Corp I
CSTA
$31M 0.8%
3,064,280
-30,100
-1% -$301K
AGGR
30
DELISTED
Agile Growth Corp
AGGR
$30.6M 0.79%
3,035,948
+172,990
+6% +$1.73M
KRNL
31
DELISTED
Kernel Group Holdings, Inc. Class A Ordinary Shares
KRNL
$30.1M 0.78%
2,982,563
+712,751
+31% +$7.14M
CPAR
32
DELISTED
Catalyst Partners Acquisition Corp. Class A Ordinary Share
CPAR
$29.9M 0.77%
2,970,621
+2,005,465
+208% +$20M
CHAA
33
DELISTED
Catcha Investment Corp
CHAA
$29.9M 0.77%
2,963,601
-10,198
-0.3% -$102K
GSQD
34
DELISTED
G Squared Ascend I Inc.
GSQD
$29.6M 0.77%
2,925,867
+1,023,156
+54% +$10.2M
HCMA
35
DELISTED
HCM Acquisition Corp Class A Ordinary Shares
HCMA
$29.3M 0.76%
2,856,204
+729,373
+34% +$7.44M
KIII
36
DELISTED
Kismet Acquisition Three Corp. Class A Ordinary Shares
KIII
$28.7M 0.74%
2,860,000
-2,000
-0.1% -$19.9K
ESM
37
DELISTED
ESM Acquisition Corporation
ESM
$28.6M 0.74%
2,837,332
+974,155
+52% +$9.75M
SPKB
38
DELISTED
Silver Spike Acquisition Corp II Class A Ordinary Shares
SPKB
$28.5M 0.74%
2,824,470
+615,843
+28% +$6.16M
LCAA
39
DELISTED
L Catterton Asia Acquisition Corp Class A Ordinary Shares
LCAA
$28.5M 0.74%
2,819,282
+920,631
+48% +$9.21M
BLUA
40
DELISTED
BlueRiver Acquisition Corp.
BLUA
$28.4M 0.74%
2,818,371
-2,600
-0.1% -$26K
STRE
41
DELISTED
Supernova Partners Acquisition Company III, Ltd.
STRE
$28.2M 0.73%
2,794,840
+473,636
+20% +$4.74M
MAXR
42
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$27.6M 0.71%
+533,751
New +$14.7M
POW
43
DELISTED
Powered Brands Class A Ordinary Shares
POW
$27.4M 0.71%
2,709,680
+684,979
+34% +$6.87M
NVSA
44
DELISTED
New Vista Acquisition Corp Class A Ordinary Shares
NVSA
$27.3M 0.71%
2,701,920
+927,490
+52% +$9.27M
FTEV
45
DELISTED
FinTech Evolution Acquisition Group
FTEV
$27.2M 0.7%
2,689,058
+137,032
+5% +$1.37M
LVRA
46
DELISTED
Levere Holdings Corp. Class A Ordinary Shares
LVRA
$27.1M 0.7%
2,686,038
-8,604
-0.3% -$85.8K
SCOB
47
DELISTED
ScION Tech Growth II Class A Ordinary Shares
SCOB
$27M 0.7%
2,666,699
+1,349,312
+102% +$13.5M
SDST
48
Stardust Power Inc
SDST
$13.8M
$25.7M 0.67%
254,432
+103,432
+68% +$10.4M
NCAC
49
DELISTED
Newcourt Acquisition Corp Class A Ordinary Share
NCAC
$25.5M 0.66%
2,484,999
+1,045,764
+73% +$10.7M
ROSS
50
DELISTED
Ross Acquisition Corp II
ROSS
$24.7M 0.64%
2,440,932
+1,898,405
+350% +$19M

Similar funds

Glazer Capital LLC's Q4 2022 Portfolio in Review

As of Q4 2022, Glazer Capital LLC held 821 positions worth $3.86B, down 29% from $5.46B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Glazer Capital LLC withdrew a net $1.68B in Q4 2022, closing 295 positions and reducing 93 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $187M position sold in full.

By sector, the portfolio is most concentrated in Financials at 69% of assets, up from 64% a quarter earlier, followed by Technology and Industrials.

Against the trend, Glazer Capital LLC opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $41M.

  • Glazer Capital LLC's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 360,496 shares worth $41M.
  • Glazer Capital LLC added most to Jaws Mustang Acquisition Corp. in Q4 2022, an estimated $52.5M increase.
  • Glazer Capital LLC's biggest Q4 2022 reduction was Envoy Medical, cutting an estimated $34M.
  • Glazer Capital LLC fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $187M.
  • Glazer Capital LLC's ten largest holdings make up 19% of its $3.86B portfolio in Q4 2022.
  • Glazer Capital LLC opened 112 new positions and closed 295 in Q4 2022.
  • Glazer Capital LLC's portfolio value fell 29% quarter-over-quarter to $3.86B.

Based on Glazer Capital LLC's 13F filing for Q4 2022, filed 14 Feb 2023.